Announcement for CBTRUS 2022 Report Publication

  • 1.  Announcement for CBTRUS 2022 Report Publication

    Posted 10-12-2022 02:41 PM
    2022 CBTRUS Report Available

    The Central Brain Tumor Registry of the United States (CBTRUS) announces the publication by Oxford University Press of its latest report, CBTRUS Statistical Report: Primary Brain and Other Central Nervous System (CNS) Tumors Diagnosed in the United States in 2015-2019. The Report is a Supplement to the Society for Neuro-Oncology's journal, Neuro-Oncology, and is available online at through a Free-to-View web link by clicking on Reports and Tables. Data collected by the CDC's National Program of Cancer Registries and NCI's Surveillance Epidemiology and End Results program were analyzed resulting in an incidence rate of 24.71 cases per 100,000 [7.02 per 100,000 for malignant tumors (126,345 cases) and 17.69 per 100,000 for non-malignant tumors (319,447 cases)] for all primary brain and other central nervous system tumors in 2015-2019. Approximately 28.3% of all brain and other CNS tumors were malignant and 71.7% were non-malignant, which makes non-malignant tumors more than twice as common as malignant tumors for the first time. The efforts of hospital tumor registrars, central cancer registries, and staff from NPCR and SEER to collect accurate and complete data have contributed to making this report possible.
    Partial funding of the 2022 CBTRUS Report was provided by CDC under Contract No.75D30119C06056 Amendment /Modification No.00002. The contents in this report are solely the responsibility of the authors and do not necessarily represent the official views either of the CDC or the NCI.
    Thank you!

    Carol Kruchko
    President & Chief Mission Officer
    Central Brain Tumor Registry of the United States (CBTRUS)
    625 South County Line Road
    Hinsdale, Illinois 60521 USA
    +1 (630) 655-4786 office
    +1 (323) 807-0556 mobile